-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOCON'S PERTUZUMAB BECOMES FIRST BIOSIMILAR TO SECURE EMA CHMP APPROVAL RECOMMENDATION UNDER NEW TAILORED CLINICAL APPROACH

Reuters·09/22/2026 11:57:00

Please log in to view news